About

Part 1Our story

Remissiva is for readers who meet dense disease-course language in a paper or listing and want a calm translation.

Each note defines terms and points you back to the protocol or your clinician for anything personal.

Part 2Where we draw the line

We do not give medical advice, recruit or enroll anyone in a study, match you with studies or sites, or share your details with anyone who might want to sell you something.

Remissiva is published by The Nelson M Group LLC. It is an educational website only.

Part 3How the guides are made

The Remissiva editors at The Nelson M Group LLC write each guide from general, publicly available guidance, including guidance from the NIH, the FDA and the public ClinicalTrials.gov registry. Every article states when it was last reviewed, and all of them get another look at least yearly.

Spotted something wrong? Write to [email protected] with “Correction” in the subject line and we will look at it. If something here differs from your own official documents, those documents win.

Part 4Facts in brief